HBEGF and glioblastoma: CRM‐197 is a clinically approved ligand for addressing diphtheria toxin receptor (DTR) and facilitates efficient delivery across BBB toward the targeted site.[211] In vitro studies in human glioblastoma cell lines confirmed transcytosis across the BBB.